"Designing Growth Strategies is in our DNA"

Biological Derived Devices Market Size, Share & Industry Analysis, By Application (Regenerative Medicine, Diabetes, Neurology, Oncology, Orthopedics, Others), By End User (Hospitals, Specialty clinics, Others) And Regional Forecast 2022-2029

Region : Global | Report ID: FBI105041 | Status : Ongoing



Biological derived devices are machines, instruments, materials, or others that are purposed for the safe and effective prevention, treatment, diagnosis, and rehabilitation of illness and disease for human beings. The Biological derived are mostly used in applications such as regenerative medicine, neurology, orthopedics, and few others. The industry is primarily driven by increasing incidence of injuries pertaining to spinal chord, cardiovascular disorders, weakening of bones and lowering of bone density and many other factors.

Technological advancements has led to increasing demand for therapeutic repairs such as stem cell treatments, replacement of cartilage, bone growth stimulators and biopharmaceuticals, thereby offering lucrative growth opportunities for the biological derived devices industry. Moreover, the growth of this market is predominantly attributed to factors such as the increasing demand for synthetic cells & synthetic genes, varied range of applications for molecular biology, declining cost of DNA synthesizing and sequencing, rising funds for research and development of synthetic biology, and increasing investments in the market.

However, the high cost associated with these devices is projected to limit the adoption in emerging countries of Asia Pacific and Latin America.

Key Market Driver -

Technological advancements in biological derived devices

Key Market Restraint -

High cost of devices could limit adoption in emerging countries

Market Segmentation:

Globally, the biological derived devices market can be categorized on the basis of application, end user and region. Among the segmentation of application, the market can be categorized regenerative medicine, neurology, oncology, orthopedics, diabetes, and others. Based on end user the market can be further classified as hospitals, specialty clinics, and others.

Geographically, the Biological Derived Devices market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the Biological Derived Devices market are Integra LifeSciences Corporation, B. Braun Melsungen AG, NuVasive, Inc., Osiris Therapeutics Inc., STEMCELL Technologies Inc., Zimmer Biomet Holdings, Inc. Celgene Corporation, Bioventus LLC, BD Diagnostics, TERUMO BCT, INC., Thermo Fisher Scientific, Inc., and others.

Key Insights:

  • New Product Launches by Key Players

  • Key Industry Trends

  • Key Industry Developments – Merger, Acquisitions, and Partnerships

  • Technological Advancements in Biological Derived Devices

  • COVID-19 Impact on Biological Derived Devices Market

Regional Analysis:

Based on segmentation of geography, the Biological Derived Devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North American region is expected to dominate the global Biological Derived Devices market. The factors driving the market in the region are greater technological advancement, higher investment in research and development by the government, and larger presence of key players.

On the other hand, the market in Europe is driven by factors such as higher funding in research institutes by the government. Increasing affordability and evolving healthcare infrastructure of countries such as China and India is projected to positively influence the growth of the market in Asia Pacific. Developments in public and private healthcare sectors in countries of Latin America and Middle East and Africa is anticipated to surge the market growth in these region.

To gain extensive insights into the market, Request for Customization




By Application

  • Regenerative Medicine

  • Diabetes

  • Neurology

  • Oncology

  • Orthopedics

  • Others

By End User

  • Hospitals

  • Specialty clinics

  • Others

By Geography

  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Biological Derived Devices Market Industry Developments

  • IN June 2020, Illumina, Inc. is focused on enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers.

  • In November 2019, Takara Bio Inc., has launched the world’s first commercially available small intestinal epithelial cells derived from human induced pluripotent stem cells. The new Cellartis Intestinal Epithelial Cells (from ChiPSC18) Kit was jointly developed when Takara Bio received a technology transfer from a differentiation induction method to derive these cells from hiPSCs

  • Ongoing
  • 2021
  • 2018-2020


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.